(Q37246186)

19 August 2017

Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study (English)

1 reference

19 August 2017

0 references

1 reference

1

Melena D Bellin

1 reference

19 August 2017

Theresa Laguna

2

1 reference

19 August 2017

Janice Leschyshyn

3

1 reference

19 August 2017

Warren Regelmann

4

1 reference

19 August 2017

Jordan Dunitz

5

1 reference

19 August 2017

JoAnne Billings

6

1 reference

19 August 2017

Antoinette Moran

7

1 reference

19 August 2017

13 March 2013

1 reference

19 August 2017

1 reference

19 August 2017

14

1 reference

19 August 2017

417-421

1 reference

19 August 2017

6

1 reference

Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Pharmacology of CFTR chloride channel activity.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

Early onset diabetes mellitus. Tip or iceberg?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3804832

3 December 2018

Identifiers

DOI

10.1111/PEDI.12026

1 reference

19 August 2017

1 reference

19 August 2017

1 reference